Literature DB >> 6860214

Ocular infection with herpes simplex virus in nonimmune and immune mice.

A B Tullo, C Shimeld, W A Blyth, T J Hill, D L Easty.   

Abstract

In a detailed study of ocular infection by herpes simplex virus (HSV) type 1 in mice, the course and signs of eye disease were investigated and compared in primary and secondary infection using slit-lamp examination, culture of the tear film, and monitoring of the blink reflex. Response to primary inoculation ranged from subclinical infection to severe keratitis. Compared with conjunctival scarification, corneal scarification resulted in more frequent and severe eye disease and signs of CNS infection. Previous infection in the skin of the contralateral ear considerably modified subsequent infection of the eye so that signs of disease occurred earlier, were limited to dendritic keratitis with some stromal involvement, and were largely reversible. The mouse seems to be a suitable animal for studying ocular infection with HSV.

Entities:  

Mesh:

Year:  1983        PMID: 6860214     DOI: 10.1001/archopht.1983.01040010961023

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  17 in total

1.  Human herpesviruses in the cornea.

Authors:  S B Kaye; K Baker; R Bonshek; H Maseruka; E Grinfeld; A Tullo; D L Easty; C A Hart
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  A novel mouse model for neurotrophic keratopathy: trigeminal nerve stereotactic electrolysis through the brain.

Authors:  Giulio Ferrari; Sunil K Chauhan; Hiroki Ueno; Nambi Nallasamy; Stefano Gandolfi; Lawrence Borges; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-19       Impact factor: 4.799

3.  The histology of the eye after zosteriform spread of herpes simplex virus in the mouse.

Authors:  C Claoue; T Hodges; T Hill; W Blyth; D Easty
Journal:  Br J Exp Pathol       Date:  1987-08

4.  Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine.

Authors:  M Erturk; T J Hill; C Shimeld; R Jennings
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge.

Authors:  H Ghiasi; D C Roopenian; S Slanina; S Cai; A B Nesburn; S L Wechsler
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

6.  Antigen presentation of herpes simplex virus by corneal epithelium--an in vitro and in vivo study.

Authors:  G T Fahy; D C Hooper; D L Easty
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

7.  Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring.

Authors:  H Ghiasi; S Cai; G C Perng; A B Nesburn; S L Wechsler
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

8.  Non-traumatic acquisition of herpes simplex virus infection through the eye.

Authors:  S B Kaye; C Shimeld; E Grinfeld; N J Maitland; T J Hill; D L Easty
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

9.  Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice.

Authors:  C M Richards; R Case; T R Hirst; T J Hill; N A Williams
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.

Authors:  L A Morrison; D M Knipe
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.